Doximity, Inc. (NASDAQ:DOCS) Holdings Lifted by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA increased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 547.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 106,727 shares of the company's stock after purchasing an additional 90,232 shares during the quarter. Pictet Asset Management Holding SA owned 0.06% of Doximity worth $5,698,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in DOCS. New Age Alpha Advisors LLC bought a new position in Doximity in the fourth quarter worth about $485,000. Norges Bank acquired a new stake in shares of Doximity during the 4th quarter worth approximately $4,368,000. Loomis Sayles & Co. L P lifted its holdings in shares of Doximity by 2.7% in the 4th quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock worth $124,644,000 after purchasing an additional 62,366 shares during the last quarter. WINTON GROUP Ltd acquired a new position in Doximity during the 4th quarter valued at approximately $585,000. Finally, Vanguard Group Inc. grew its stake in Doximity by 4.5% during the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock worth $598,159,000 after buying an additional 485,102 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Stock Down 3.5 %

Doximity stock traded down $1.86 during mid-day trading on Tuesday, hitting $50.54. The company's stock had a trading volume of 2,637,843 shares, compared to its average volume of 1,957,193. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The stock's fifty day moving average price is $65.16 and its two-hundred day moving average price is $55.24. The stock has a market capitalization of $9.43 billion, a P/E ratio of 50.54, a P/E/G ratio of 4.10 and a beta of 1.41.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DOCS shares. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Bank of America lifted their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Needham & Company LLC upped their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and raised their price target for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Finally, Mizuho boosted their price objective on Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $64.22.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 37.40% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.